Cullen/Frost Bankers’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-4,986
Closed -$389K 380
2016
Q2
$389K Sell
4,986
-2,010
-29% -$143K 0.01% 291
2016
Q1
$385K Sell
6,996
-20
-0.3% -$1.09K 0.01% 289
2015
Q4
$433K Hold
7,016
0.02% 283
2015
Q3
$443K Sell
7,016
-9
-0.1% -$642 0.02% 283
2015
Q2
$513K Sell
7,025
-150
-2% -$10.8K 0.02% 295
2015
Q1
$469K Buy
7,175
+139
+2% +$9.24K 0.02% 302
2014
Q4
$458K Sell
7,036
-10
-0.1% -$644 0.02% 312
2014
Q3
$424K Buy
+7,046
New +$460K 0.02% 311

Other funds holding STJ

Cullen/Frost Bankers's STJ Position: Q3 2016 in Review

Cullen/Frost Bankers sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 4,986 shares — an estimated $389K sold.

Cullen/Frost Bankers first reported a position in STJ in Q3 2014 and held it in 8 quarters. The position peaked at $513K in Q2 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Cullen/Frost Bankers reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Cullen/Frost Bankers sold 4,986 St Jude Medical shares in Q3 2016, an estimated $389K.
  • Cullen/Frost Bankers first reported a position in St Jude Medical in Q3 2014 and held it in 8 quarters.
  • Cullen/Frost Bankers's St Jude Medical position peaked at $513K in Q2 2015.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Cullen/Frost Bankers's 13F filing for Q3 2016, filed 20 Oct 2016.